BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36099049)

  • 1. Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.
    Rutella S; Vadakekolathu J; Mazziotta F; Reeder S; Yau TO; Mukhopadhyay R; Dickins B; Altmann H; Kramer M; Knaus HA; Blazar BR; Radojcic V; Zeidner JF; Arruda A; Wang B; Abbas HA; Minden MD; Tasian SK; Bornhäuser M; Gojo I; Luznik L
    J Clin Invest; 2022 Nov; 132(21):. PubMed ID: 36099049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy.
    Knaus HA; Berglund S; Hackl H; Blackford AL; Zeidner JF; Montiel-Esparza R; Mukhopadhyay R; Vanura K; Blazar BR; Karp JE; Luznik L; Gojo I
    JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia.
    Wang P; Zhang Y; Cai Q; Long Q; Pan S; Zhou W; Deng T; Mo W; Wang S; Zhang Y; Wang C; Chen C
    Ann Med; 2023 Dec; 55(1):2201507. PubMed ID: 37070487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
    Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
    Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer.
    Tang H; Wu H; Jian Y; Ji T; Wu B; Wu Y; Wang P; Cao T
    Int Immunopharmacol; 2024 May; 132():111949. PubMed ID: 38552290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia.
    Xu Q; Cao D; Fang B; Yan S; Hu Y; Guo T
    Cancer Med; 2022 Sep; 11(17):3364-3380. PubMed ID: 35355427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
    Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
    Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate acid promotes PD-1
    Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
    Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
    Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.
    Masarova L; Kantarjian H; Garcia-Mannero G; Ravandi F; Sharma P; Daver N
    Adv Exp Med Biol; 2017; 995():73-95. PubMed ID: 28321813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
    Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
    Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B
    Front Immunol; 2023; 14():1139517. PubMed ID: 36960073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia.
    Zhong F; Yang Y; Yao F; Liu J; Yu X; Wang XL; Huang B; Wang XZ
    Aging (Albany NY); 2023 Oct; 15(20):11217-11226. PubMed ID: 37845004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia.
    Tang L; Wu J; Li CG; Jiang HW; Xu M; Du M; Yin Z; Mei H; Hu Y
    Clin Cancer Res; 2020 Apr; 26(7):1763-1772. PubMed ID: 31911547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8
    Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
    Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.
    Jiang F; Mao Y; Lu B; Zhou G; Wang J
    Sci Rep; 2021 Jul; 11(1):14657. PubMed ID: 34282207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.
    Ma P; Sun W
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14597-14617. PubMed ID: 37580402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T-lymphocytes in acute myeloid leukemia: Monitoring prognosis and guiding treatment choice.
    Lu M; Yu X; Hu J; Wang J; Wang T
    J Gene Med; 2024 Jan; 26(1):e3587. PubMed ID: 37697474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
    Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
    EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.